NVO logo

Novo Nordisk A/S (NVO) Cash from investing

annual CFI:

-$18.70B-$12.33B(-193.47%)
December 31, 2024

Summary

  • As of today (May 29, 2025), NVO annual cash flow from investing activities is -$18.70 billion, with the most recent change of -$12.33 billion (-193.47%) on December 31, 2024.
  • During the last 3 years, NVO annual CFI has fallen by -$13.67 billion (-271.87%).
  • NVO annual CFI is now -68847.23% below its all-time high of -$27.12 million, reached on December 31, 1995.

Performance

NVO Cash from investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVOcash flow metrics

quarterly CFI:

-$940.79M+$12.21B(+92.84%)
March 31, 2025

Summary

  • As of today (May 29, 2025), NVO quarterly cash flow from investing activities is -$940.79 million, with the most recent change of +$12.21 billion (+92.84%) on March 31, 2025.
  • Over the past year, NVO quarterly CFI has dropped by -$1.52 billion (-263.27%).
  • NVO quarterly CFI is now -263.27% below its all-time high of $576.22 million, reached on March 31, 2024.

Performance

NVO quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVOcash flow metrics

TTM CFI:

-$20.22B-$1.52B(-8.11%)
March 31, 2025

Summary

  • As of today (May 29, 2025), NVO TTM cash flow from investing activities is -$20.22 billion, with the most recent change of -$1.52 billion (-8.11%) on March 31, 2025.
  • Over the past year, NVO TTM CFI has dropped by -$15.38 billion (-317.93%).
  • NVO TTM CFI is now -22769.64% below its all-time high of $89.19 million, reached on March 31, 2004.

Performance

NVO TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVOcash flow metrics

Cash from investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

NVO Cash from investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-193.5%-263.3%-317.9%
3 y3 years-271.9%-227.0%-325.4%
5 y5 years-983.7%-202.6%-1182.8%

NVO Cash from investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-429.4%at low-263.3%+92.8%-472.4%at low
5 y5-year-983.7%at low-263.3%+92.8%-1389.8%at low
alltimeall time<-9999.0%at low-263.3%+92.8%<-9999.0%at low

NVO Cash from investing History

DateAnnualQuarterlyTTM
Mar 2025
-
-$940.79M(-92.8%)
-$20.22B(+8.1%)
Dec 2024
-$18.70B(+193.5%)
-$13.15B(+319.9%)
-$18.70B(+144.0%)
Sep 2024
-
-$3.13B(+4.5%)
-$7.66B(+18.6%)
Jun 2024
-
-$3.00B(-620.2%)
-$6.47B(+33.6%)
Mar 2024
-
$576.22M(-127.3%)
-$4.84B(-24.1%)
Dec 2023
-$6.37B(+80.4%)
-$2.11B(+9.3%)
-$6.37B(+1.2%)
Sep 2023
-
-$1.93B(+41.0%)
-$6.29B(+26.2%)
Jun 2023
-
-$1.37B(+42.9%)
-$4.99B(+18.6%)
Mar 2023
-
-$958.59M(-52.9%)
-$4.20B(+19.0%)
Dec 2022
-$3.53B(-29.8%)
-$2.03B(+225.9%)
-$3.53B(-26.1%)
Sep 2022
-
-$624.14M(+6.4%)
-$4.78B(-1.8%)
Jun 2022
-
-$586.61M(+103.9%)
-$4.87B(+2.5%)
Mar 2022
-
-$287.67M(-91.2%)
-$4.75B(-5.5%)
Dec 2021
-$5.03B(+46.3%)
-$3.28B(+361.1%)
-$5.03B(+36.5%)
Sep 2021
-
-$712.41M(+52.4%)
-$3.68B(-6.9%)
Jun 2021
-
-$467.55M(-17.1%)
-$3.96B(+7.2%)
Mar 2021
-
-$564.29M(-70.9%)
-$3.69B(+7.4%)
Dec 2020
-$3.44B(+99.2%)
-$1.94B(+96.9%)
-$3.44B(+73.0%)
Sep 2020
-
-$985.15M(+387.7%)
-$1.99B(+46.4%)
Jun 2020
-
-$201.98M(-35.0%)
-$1.36B(-13.9%)
Mar 2020
-
-$310.91M(-36.5%)
-$1.58B(-8.7%)
Dec 2019
-$1.73B(-9.8%)
-$489.26M(+37.8%)
-$1.73B(-9.4%)
Sep 2019
-
-$354.97M(-15.7%)
-$1.91B(-3.5%)
Jun 2019
-
-$420.93M(-8.6%)
-$1.98B(+1.3%)
Mar 2019
-
-$460.53M(-31.2%)
-$1.95B(+1.9%)
Dec 2018
-$1.91B(+91.3%)
-$668.98M(+57.5%)
-$1.91B(+12.2%)
Sep 2018
-
-$424.66M(+7.4%)
-$1.71B(+5.9%)
Jun 2018
-
-$395.27M(-6.9%)
-$1.61B(+21.5%)
Mar 2018
-
-$424.64M(-8.0%)
-$1.33B(+32.5%)
Dec 2017
-$1.00B(-0.9%)
-$461.63M(+40.3%)
-$1.00B(+6.5%)
Sep 2017
-
-$329.06M(+198.1%)
-$939.19M(-6.9%)
Jun 2017
-
-$110.38M(+11.3%)
-$1.01B(+15.8%)
Mar 2017
-
-$99.13M(-75.3%)
-$870.94M(-13.7%)
Dec 2016
-$1.01B(+11.2%)
-$400.61M(+0.4%)
-$1.01B(-22.8%)
Sep 2016
-
-$398.83M(-1543.0%)
-$1.31B(-6.5%)
Jun 2016
-
$27.64M(-111.6%)
-$1.40B(-1.8%)
Mar 2016
-
-$237.45M(-66.0%)
-$1.42B(+56.9%)
Dec 2015
-$907.22M(+146.4%)
-$698.28M(+42.5%)
-$907.22M(+85.0%)
Sep 2015
-
-$490.12M(<-9900.0%)
-$490.48M(+161.6%)
Jun 2015
-
$2.19M(-99.2%)
-$187.47M(+13.3%)
Mar 2015
-
$278.99M(-199.1%)
-$165.51M(-55.0%)
Dec 2014
-$368.14M(-25.4%)
-$281.54M(+50.5%)
-$368.14M(+104.4%)
Sep 2014
-
-$187.12M(-874.7%)
-$180.14M(-48.4%)
Jun 2014
-
$24.15M(-68.4%)
-$348.92M(+0.3%)
Mar 2014
-
$76.37M(-181.6%)
-$347.84M(-29.6%)
Dec 2013
-$493.76M(-29.7%)
-$93.55M(-73.7%)
-$493.76M(-28.6%)
Sep 2013
-
-$355.89M(-1510.6%)
-$691.26M(+9.7%)
Jun 2013
-
$25.23M(-136.3%)
-$630.28M(+17.9%)
Mar 2013
-
-$69.55M(-76.1%)
-$534.54M(-23.9%)
DateAnnualQuarterlyTTM
Dec 2012
-$702.86M(+8.8%)
-$291.05M(-1.3%)
-$702.86M(-20.3%)
Sep 2012
-
-$294.91M(-343.8%)
-$882.14M(+26.0%)
Jun 2012
-
$120.97M(-150.9%)
-$700.34M(-19.0%)
Mar 2012
-
-$237.87M(-49.4%)
-$864.76M(+33.8%)
Dec 2011
-$646.16M(-34.9%)
-$470.33M(+315.8%)
-$646.16M(-22.0%)
Sep 2011
-
-$113.11M(+160.3%)
-$827.89M(-4.6%)
Jun 2011
-
-$43.46M(+125.6%)
-$867.50M(-8.9%)
Mar 2011
-
-$19.26M(-97.0%)
-$952.61M(-4.1%)
Dec 2010
-$993.22M(+74.2%)
-$652.06M(+327.0%)
-$993.22M(+79.6%)
Sep 2010
-
-$152.72M(+18.8%)
-$552.96M(-1.8%)
Jun 2010
-
-$128.56M(+114.7%)
-$563.06M(+4.6%)
Mar 2010
-
-$59.87M(-71.7%)
-$538.45M(-5.5%)
Dec 2009
-$570.06M(+108.9%)
-$211.81M(+30.1%)
-$570.06M(+36.8%)
Sep 2009
-
-$162.82M(+56.6%)
-$416.86M(+21.4%)
Jun 2009
-
-$103.96M(+13.6%)
-$343.26M(+10.8%)
Mar 2009
-
-$91.48M(+56.1%)
-$309.92M(+13.6%)
Dec 2008
-$272.92M(-2.3%)
-$58.61M(-34.3%)
-$272.92M(+47.6%)
Sep 2008
-
-$89.22M(+26.3%)
-$184.92M(-12.9%)
Jun 2008
-
-$70.62M(+29.6%)
-$212.31M(-16.8%)
Mar 2008
-
-$54.47M(-285.4%)
-$255.29M(-8.6%)
Dec 2007
-$279.31M(-34.2%)
$29.39M(-125.2%)
-$279.31M(-36.3%)
Sep 2007
-
-$116.60M(+2.6%)
-$438.79M(-6.0%)
Jun 2007
-
-$113.60M(+44.7%)
-$466.94M(-3.5%)
Mar 2007
-
-$78.50M(-39.7%)
-$484.09M(+14.1%)
Dec 2006
-$424.44M(-48.2%)
-$130.09M(-10.1%)
-$424.44M(-37.3%)
Sep 2006
-
-$144.75M(+10.7%)
-$677.18M(-5.3%)
Jun 2006
-
-$130.75M(+593.5%)
-$714.87M(+0.8%)
Mar 2006
-
-$18.85M(-95.1%)
-$709.38M(-13.4%)
Dec 2005
-$819.18M(+143.2%)
-$382.83M(+109.8%)
-$819.18M(+27.9%)
Sep 2005
-
-$182.44M(+45.7%)
-$640.31M(+5.9%)
Jun 2005
-
-$125.25M(-2.6%)
-$604.58M(+9.0%)
Mar 2005
-
-$128.66M(-36.9%)
-$554.70M(+64.7%)
Dec 2004
-$336.85M(-4.5%)
-$203.96M(+39.0%)
-$336.85M(+153.5%)
Sep 2004
-
-$146.71M(+94.7%)
-$132.89M(-1061.8%)
Jun 2004
-
-$75.37M(-184.5%)
$13.82M(-84.5%)
Mar 2004
-
$89.19M
$89.19M
Dec 2003
-$352.84M(-36.7%)
-
-
Dec 2002
-$557.51M(+12.4%)
-
-
Dec 2001
-$495.99M(+57.4%)
-
-
Dec 2000
-$315.16M(+69.9%)
-
-
Dec 1999
-$185.55M(-28.6%)
-
-
Dec 1998
-$259.88M(-48.0%)
-
-
Dec 1997
-$499.80M(+72.3%)
-
-
Dec 1996
-$290.06M(+969.4%)
-
-
Dec 1995
-$27.12M(-92.4%)
-
-
Dec 1994
-$355.36M(-21.6%)
-
-
Dec 1993
-$453.45M(+14.4%)
-
-
Dec 1992
-$396.48M(+42.3%)
-
-
Dec 1991
-$278.56M(+0.5%)
-
-
Dec 1990
-$277.15M
-
-

FAQ

  • What is Novo Nordisk A/S annual cash flow from investing activities?
  • What is the all time high annual CFI for Novo Nordisk A/S?
  • What is Novo Nordisk A/S annual CFI year-on-year change?
  • What is Novo Nordisk A/S quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Novo Nordisk A/S?
  • What is Novo Nordisk A/S quarterly CFI year-on-year change?
  • What is Novo Nordisk A/S TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Novo Nordisk A/S?
  • What is Novo Nordisk A/S TTM CFI year-on-year change?

What is Novo Nordisk A/S annual cash flow from investing activities?

The current annual CFI of NVO is -$18.70B

What is the all time high annual CFI for Novo Nordisk A/S?

Novo Nordisk A/S all-time high annual cash flow from investing activities is -$27.12M

What is Novo Nordisk A/S annual CFI year-on-year change?

Over the past year, NVO annual cash flow from investing activities has changed by -$12.33B (-193.47%)

What is Novo Nordisk A/S quarterly cash flow from investing activities?

The current quarterly CFI of NVO is -$940.79M

What is the all time high quarterly CFI for Novo Nordisk A/S?

Novo Nordisk A/S all-time high quarterly cash flow from investing activities is $576.22M

What is Novo Nordisk A/S quarterly CFI year-on-year change?

Over the past year, NVO quarterly cash flow from investing activities has changed by -$1.52B (-263.27%)

What is Novo Nordisk A/S TTM cash flow from investing activities?

The current TTM CFI of NVO is -$20.22B

What is the all time high TTM CFI for Novo Nordisk A/S?

Novo Nordisk A/S all-time high TTM cash flow from investing activities is $89.19M

What is Novo Nordisk A/S TTM CFI year-on-year change?

Over the past year, NVO TTM cash flow from investing activities has changed by -$15.38B (-317.93%)
On this page